- Researchers at MSKCC found that in addition to higher rates of physician-detected melanomas, doctors also are more likely to detect thinner lesions, or cancers in the earliest stages.
- A MSKCC study predicts improved survival in primary mediastinal nonseminomatous germ cell tumors.
- Gregory Riely of MSKCC was quoted in a Reuters article about the potential unreliability of CT scans to measure long tumors.
Author Archives: Mark
MSKCC in the News: May 14 – June 10
- MSKCC’s Dr. Dennis Chi was recently interviewed on a WCBS news piece about the successful results of a patient treated with modified radical abdominal trachelectomy for cervical cancer, which successfully preserved her fertility.
- A recent New York Times op-ed entitled, Why Medical School Should Be Free, was co-authored by MSKCC’s Peter B. Bach.
- In a BBC News article covering the annual meeting of the American Society of Clinical Oncology in Chicago, clinicians from MSKCC reported on two separate studies carried out at Sloan-Kettering in which two new drugs had improved survival rates of patients with inoperable melanoma, the deadliest forms of skin cancer.
MSKCC in the News: April 9 – April 20
- In a recent New York Times Magazine article entitled “Is Sugar Toxic,” MSKCC president Craig Thompson suggests a link between high sugar consumption and the development of insulin dependent cancer cells resulting in tumor growth.
- The New York Daily News reported on a new MSKCC clinical trial to save the fertility of young boys undergoing cancer treatment.
- Pharmabiz posted an announcement about the research collaboration between MSKCC and Molecular Templates to develop Engineered Toxin Bodies (ETB) for lymphomas.